ARTHROPLASTY LIMITED
Opportunity 80/100 (exceptional), bankability 75/100. Strong seller-intent signal (83/100, director aged 68). Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (73/100).
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Strong composite across quality, acquirability, and risk. High-priority target — progress to serious diligence.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2025-09-30 | 2024-09-30 |
|---|---|---|
| Total assets | — | £306.3k |
| Current assets | — | £339.8k |
| Cash | — | £338.5k |
| Debtors | — | £1.3k |
| Net assets | — | £306.3k |
| Average employees | 1 | — |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
2 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 accounts
- • 1 accounts
Corporate timeline (19 events)Click to expand
- 2026-06-19📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2025-06-27📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-04-16📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-06-15📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2022-10-10📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2022-04-11📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2021-07-09📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2020-08-04📄resolutionresolution · RESOLUTIONS
- 2020-08-04📄capital-name-of-class-of-sharescapital · SH08
- 2020-08-04📄resolutionresolution · RESOLUTIONS
- 2020-08-04📄memorandum-articlesincorporation · MA
- 2020-07-02📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2019-07-11📄accounts-amended-with-accounts-type-micro-entityaccounts · AAMD
- 2019-07-03📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2018-06-25📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2017-10-12📄withdrawal-of-a-person-with-significant-control-statementpersons-with-significant-control · PSC09
- 2017-10-12📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC01
- 2010-10-01🏢Company incorporatedAs ARTHROPLASTY LIMITED
- 2010-10-01➕SARIN, Rajesh appointeddirector
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Long-tenure founder: Senior director has been in place 16 years — deep operational knowledge concentrated in one person.
- +Founder age: Director aged approximately 68 — succession pressure is live.
- +No director turnover: Company is 16 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Strong acquirability signals converging. Worth approaching directly — this is how off-market deals start.
- primaryFounder aged 63+: Senior director is approximately 68. Approaching typical UK retirement age — succession thinking likely.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
- secondary12+ year tenure: Director in role 16 years.
- secondaryStable-but-static management: Company is 16 years old and no new directors in the last 3 years — succession not yet being planned internally.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Rajesh Sarin Individual · British · DOB 05/1958 · age 68 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 06/04/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · BL postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A&S RIPON LIMITED→ 15275798 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ANITANY LIMITED→ 10543938 · est 2017 · no financials extracted | — | — | — | — | 9y | — | — |
| APOORVA MEDICAL SERVICES LIMITED→ 12531956 · est 2020 · no financials extracted | — | — | — | — | 6y | — | — |
| ARDIN PHYSIOTHERAPY LIMITED→ 08837215 · est 2014 · no financials extracted | — | — | — | — | 12y | — | — |
| ARIEIA SKIN CLINIC LTD→ 16438252 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ARIETIS HEALTHCARE UK LIMITED→ 12830678 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| ARK AUDIOLOGISTS LIMITED→ 14162768 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| ARK HEALTHCARE SOCIAL ENTERPRISES LIMITED→ 08830392 · est 2014 · no financials extracted | — | — | — | — | 12y | — | — |
| ARSLAN MASSAGE & THERAPY LTD→ 13149969 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
| AS SMILE CARE LTD→ 15839325 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ASC HEALTHCARE LIMITED→ 08405945 · est 2013 · no financials extracted | — | — | — | — | 13y | — | — |
| ASCEND WELLBEING LIMITED→ 17049016 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.